ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric

Rheumatology Awards & Appointments

Ann-Marie Lindstrom  |  November 18, 2018

Scleroderma Foundation Names Doctor of the Year The Scleroderma Foundation has named Lesley Ann Saketkoo, MD, MPH, doctor of the year for her leadership and commitment to the scleroderma community. Dr. Saketkoo is an associate professor of clinical medicine at Tulane University School of Medicine, New Orleans. Dr. Saketkoo is an internationally recognized researcher, educator…

Filed under:AwardsProfiles Tagged with:Joyce ChangLesley Ann SaketkooPaul Hoover

A Rheumatology Fellow Shares Her Journey to Capitol Hill via the ACR’s Advocacy 101 Program

Courtney B. Crayne, MD   |  November 18, 2018

In summer 2017, I was a few months post-partum when I received an email announcing applications for the ACR’s Advocacy 101 program. It would take only a few days, but I asked my division director if it would be worth the time commitment. He questioned the career benefits of advocacy, but encouraged me to apply…

Filed under:Legislation & Advocacy Tagged with:Legislation & Advocacy

Genetic Discoveries Pave New Pathways to the Origins of Rheumatic Diseases

Carina Stanton  |  November 5, 2018

New research has provided a never-before-seen view of the genetic activity that may be used to map the polygenic nature of common rheumatic diseases. Two recent studies have employed distinct approaches to identify the non-coding gene variants, digging deep into human genetic data to uncover the mechanism of rheumatic diseases…

Filed under:Conditions Tagged with:genegeneticgenomeGWASRheumatic Disease

How to Engage Young Adult Patients

Carina Stanton  |  October 30, 2018

Gaps in healthcare are common between the ages of 17 and 21. But simple collaborations between adult and pediatric rheumatologists can go a long way to help young adults stay engaged in their rheumatology care…

Filed under:Practice Support Tagged with:Adolescentspatient carePediatric RheumatologyTransitions

FDA Approves Subcutaneous Tocilizumab for Ages 2–17

Michele B. Kaufman, PharmD, BCGP  |  October 29, 2018

The FDA has approved subcutaneous tocilizumab for treating active systemic juvenile idiopathic arthritis in pediatric patients as young as 2 years old…

Filed under:ConditionsDrug UpdatesPediatric Conditions Tagged with:FDAPediatricsJIAsubcutaneous tocilizumabsystemic juvenile idiopathic arthritistocilizumabU.S. Food and Drug Administration (FDA)

Uveitis: Know the Risk Factors, Symptoms & Treatment Options

Carina Stanton  |  October 22, 2018

Inflammatory diseases can cause uveitis. Early detection and treatment are essential, but when uveitis goes undetected it can cause blindness. Here’s how to protect your patients…

Filed under:Conditions Tagged with:eyeEye diseaseUveitisvision

Awards, Appointments & Announcements in the World of Rheumatology

Ann-Marie Lindstrom  |  October 18, 2018

Canadian Pediatric Rheumatologist Invested into Order of Canada Peter Dent, MD, professor emeritus of pediatrics at McMaster University in Hamilton, Ontario, Canada, was invested into the Order of Canada in May. The Order of Canada is the country’s highest civilian honor. “Dr. Dent has had a substantial positive impact on healthcare, in Hamilton and far…

Filed under:AwardsProfiles Tagged with:CanadaDr. Latifa FakoyaDr. Peter DentDr. Ross Petty

Granulomatosis with Polyangiitis Rates & Outcomes

Ruth Jessen Hickman, MD  |  October 18, 2018

A recent study in Arthritis & Rheumatology highlights new information about the epidemiology and disease course of the vasculitic disease granulomatosis with polyangiitis (GPA, formerly known as Wegener’s disease).1 GPA is a rare disease that’s generally specific to the lungs, kidneys and the upper airways. The study provides key new data about the incidence and…

Filed under:Vasculitis Tagged with:granulomatosis with polyangiitisWegener's Granulomatosis

Juvenile Arthritis Camps Offer Kids Freedom, Fun & Education

Linda Childers  |  October 18, 2018

With the wind in her hair and a smile on her face, a young girl flies through the air on the zip line at Camp Wekandu. She waves to her fellow campers on the ground and offers a thumbs up before the ride ends and one of the camp counselors lowers her from the zip…

Filed under:ConditionsPatient PerspectivePractice Support Tagged with:Arthritis FoundationJuvenile Arthritis (JIA)Juvenile Arthritis Camps

Study Reveals Lupus Is a Leading Cause of Death in U.S. Women

Kimberly J. Retzlaff  |  October 18, 2018

Systemic lupus erythematosus (SLE) is a leading cause of death among young women, according to an August 2018 study in Arthritis & Rheumatology.1 To help determine where SLE ranks among causes of death, Eric Y. Yen, MD, and Ram Raj Singh, MD, conducted a population-based study using nationwide mortality counts for all female residents of…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:death rateGendermortality rateRheumatology Research Foundation

  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 112
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences